SECsense Logo

Tonix Pharmaceuticals 8-K Filing: Key Updates as of February 20, 2025

$TNXP
Form 8-K
Filed on: 2025-02-21
Source
Tonix Pharmaceuticals 8-K Filing: Key Updates as of February 20, 2025

Based on the provided XML section of a financial report, here are the key pieces of information extracted:

  1. Company Information:
  • Name: Tonix Pharmaceuticals Holding Corp.
  • CIK Number: 0001430306
  • Ticker Symbol: TNXP
  • Exchange: NASDAQ
  • Address: 26 Main Street, Chatham, NJ 07928
  • Phone: (862) 904-8182
  1. Filing Details:
  • Filing Type: 8-K (Current Report)
  • Filing Date: February 20, 2025
  1. Financial Context:
  • Reporting Period: The information is as of February 20, 2025.
  • Unit of Measure:
    • Financial figures are reported in USD (United States Dollar).
    • Shares are also indicated as a unit of measurement.
  1. Additional Notes:
  • The report uses XBRL (eXtensible Business Reporting Language) for structured data representation, indicating compliance with SEC filing requirements.
  • The schema reference suggests that the filing adheres to specific data standards, which can facilitate analysis and processing by financial systems.

This information is crucial for understanding the financial and operational status of Tonix Pharmaceuticals as of the specified date. The 8-K filing typically contains significant events that shareholders should be aware of, which could impact stock performance or corporate governance.